Chronic cough, a condition characterized by a persistent cough lasting more than eight weeks, is an enigma that often challenges clinicians. Despite its prevalence, the diagnosis and management of this condition remain complex due to its multifactorial etiology and the variability in patient responses to treatment. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
A systematic approach to diagnosis is paramount. A detailed history and physical examination can provide valuable clues. The clinician should consider factors such as the duration and severity of cough, associated symptoms, exposure history, and response to previous treatments. Diagnostic tests, including imaging studies, pulmonary function tests, and bronchoscopy, can further aid in identifying the underlying cause.
Management strategies should be tailored based on the underlying cause. Empirical treatment trials for common causes such as GERD, asthma, and upper airway cough syndrome can be beneficial. For refractory cases, a multidisciplinary approach involving pulmonologists, allergists, gastroenterologists, and speech therapists may be required.
Novel therapies are emerging in the field of chronic cough management. Neuromodulators like gabapentin and pregabalin have shown promise. Research is also underway to explore the role of specific P2X3 receptor antagonists. However, the long-term safety and efficacy of these treatments need further investigation.
Chronic cough is a complex condition that requires a comprehensive and systematic approach for effective diagnosis and management. While empirical treatments remain the mainstay, the role of novel therapies is emerging. Continued research and a multidisciplinary approach are vital to enhance our understanding and management of this perplexing condition.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation